Jane Street’s Clovis Oncology, Inc. CLVS Stock Holding History

Jane Street’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-277,800	Closed	-$331K	–	10645
2022 Q3	$331K	Sell	277,800 -238,300	-46%	-$371K	﹤0.01%	7422
2022 Q2	$929K	Buy	516,100 +167,800	+48%	+$248K	﹤0.01%	5621
2022 Q1	$704K	Buy	348,300 +173,500	+99%	+$341K	﹤0.01%	6840
2021 Q4	$474K	Buy	174,800 +28,600	+20%	+$106K	﹤0.01%	7365
2021 Q3	$652K	Sell	146,200 -151,900	-51%	-$732K	﹤0.01%	6780
2021 Q2	$1.73M	Sell	298,100 -119,300	-29%	-$699K	﹤0.01%	4622
2021 Q1	$2.93M	Buy	417,400 +110,400	+36%	+$740K	﹤0.01%	3296
2020 Q4	$1.47M	Sell	307,000 -203,500	-40%	-$1.03M	﹤0.01%	4030
2020 Q3	$2.98M	Sell	510,500 -61,800	-11%	-$370K	﹤0.01%	2452
2020 Q2	$3.86M	Sell	572,300 -15,100	-3%	-$114K	﹤0.01%	2164
2020 Q1	$3.74M	Buy	587,400 +320,100	+120%	+$2.57M	﹤0.01%	1413
2019 Q4	$2.79M	Buy	267,300 +251,800	+1,625%	+$1.83M	﹤0.01%	1589
2019 Q3	$61K	Buy	+15,500	New	+$125K	﹤0.01%	4856
2019 Q2	–	Sell	-10,600	Closed	-$263K	–	5958
2019 Q1	$263K	Sell	10,600 -34,600	-77%	-$867K	﹤0.01%	4396
2018 Q4	$812K	Buy	45,200 +31,400	+228%	+$642K	﹤0.01%	2861
2018 Q3	$405K	Sell	13,800 -7,400	-35%	-$286K	﹤0.01%	3867
2018 Q2	$964K	Sell	21,200 -56,700	-73%	-$2.76M	﹤0.01%	2789
2018 Q1	$4.11M	Buy	77,900 +35,100	+82%	+$2.05M	0.01%	1125
2017 Q4	$2.91M	Buy	42,800 +19,500	+84%	+$1.36M	0.01%	1252
2017 Q3	$1.92M	Sell	23,300 -33,200	-59%	-$2.63M	0.01%	1638
2017 Q2	$5.29M	Buy	56,500 +23,700	+72%	+$1.45M	0.02%	745
2017 Q1	$2.09M	Sell	32,800 -44,300	-57%	-$2.69M	0.01%	1341
2016 Q4	$3.42M	Sell	77,100 -1,900	-2%	-$66.9K	0.01%	912
2016 Q3	$2.85M	Buy	+79,000	New	+$1.69M	0.01%	919
2016 Q2	–	Sell	-64,700	Closed	-$1.24M	–	4741
2016 Q1	$1.24M	Buy	64,700 +58,200	+895%	+$1.23M	0.01%	1651
2015 Q4	$228K	Sell	6,500 -20,300	-76%	-$1.31M	﹤0.01%	3430
2015 Q3	$2.46M	Buy	+26,800	New	+$2.32M	0.02%	819

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jane Street's CLVS Position: Q4 2022 in Review

Jane Street sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 52,609 shares — an estimated $63K sold.

Jane Street first reported a position in CLVS in Q2 2013 and held it in 29 quarters. The position peaked at $6.01M in Q3 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Jane Street reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Jane Street sold 52,609 Clovis Oncology, Inc. shares in Q4 2022, an estimated $63K.
Jane Street first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 29 quarters.
Jane Street's Clovis Oncology, Inc. position peaked at $6.01M in Q3 2017.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.